Despite a lack of large randomized trials clarifying when and in whom it might work best, use of Impella (Abiomed) for mechanical circulatory support in patients with acute MI complicated by ...

Prior to the NCSI, cardiogenic shock survival rates had stagnated for the last 20 years at around 50%. The investigators of the physician-led NCSI are implementing protocols to increase survival and ...

Several studies show that the use of percutaneous ventricular assist devices (PVADs), including Impella, is particularly cost-effective in cases of cardiogenic shock: Several studies, including ...

Johnson & Johnson (NYSE:JNJ) today shared new clinical findings from a novel U.S. pilot study of its Abiomed unit’s Impella 5.5 system.

Study conducted at 109 hospitals with oversight by 10 Japanese professional societies, including Japanese Circulation Society Figure 1 (Graphic: Business Wire) The interim analysis examined 819 ...

PHILADELPHIA -- The Impella mechanical support device, frequently used in patients in cardiogenic shock who are undergoing percutaneous coronary interventions, was more expensive than intra-aortic ...

DANVERS, Mass.--(BUSINESS WIRE)--The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Impella RP to include patients suffering from COVID-19 related ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

WASHINGTON -- A rare randomized trial and a new meta-analysis both failed to find any evidence that Impella mechanical circulatory support devices are any better than intra-aortic balloon pumps (IABPs ...

The study demonstrated Impella ECP's safety and efficacy for use in high-risk PCI. Operators chose 8Fr Angio-Seal as the first-closure method in 70% of the patients, with a 92% success rate 1.

DANVERS, Mass.--(BUSINESS WIRE)--The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular ...

Use of the Impella percutaneous left ventricular assist device (Abiomed) in acute MI complicated by cardiogenic shock (AMICS) in the United States increased nearly fivefold between 2012 and 2017, a ...